Pharmaceutics ll Exam 2 Practice

Multiparticulate controlled-release systems use many small beads or granules that can be filled into capsules or compressed into tablets. This structure lets the dose release over a broader stretch of the GI tract rather than all at once as a single large unit, which improves several aspects of performance.

Uniform distribution in the GI tract comes from the many individual units moving with peristalsis. Instead of releasing under a single site’s local conditions, the beads spread out, so variability in gastric pH, emptying rate, and regional transit has less impact on the overall release profile. This tends to smooth absorption and reduce PK variability.

Dose-dumping risk is lowered because the release is spread across many units. If a single unit fails or a coating is breached, the impact is limited to that unit, while the remaining beads continue releasing more gradually. The overall dose-time profile stays more controlled than with a single-unit system, where a fault could release a large portion at once.

Flexible dosing is another key advantage. The total dose can be adjusted by changing the number of beads or by combining beads with different coatings to tailor the release, without redesigning a new solid dosage form. This flexibility is harder to achieve with a single-unit system, where changing the dose often means manufacturing a new tablet.

Improved dissolution is facilitated by the high surface area of many small beads and by coatings that can be precisely tuned. Beads can be engineered to release at different rates, and the hydrodynamics in the GI tract interact more consistently with small units, leading to more predictable dissolution and absorption.

These factors together explain why multiparticulates offer advantages like uniform GI distribution, reduced dose-dumping risk, flexible dosing, and improved dissolution compared with single-unit systems.